Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D'Souza

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Chemico-Biological Interactions|October 2, 2010
Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxibDhimant Desai, Naveen Kaushal, Ujjawal H Gandhi, et al.
Molecular Cancer Therapeutics|April 6, 2017
Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast CancersMarcus P Kelly, Carlos Hickey, Sosina Makonnen, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Chemico-Biological Interactions|October 2, 2010
Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxibDhimant Desai, Naveen Kaushal, Ujjawal H Gandhi, et al.
Molecular Cancer Therapeutics|April 6, 2017
Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast CancersMarcus P Kelly, Carlos Hickey, Sosina Makonnen, et al.
Pageof 2